Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Barrett Business Services is a provider of business management solutions for small-and mid-sized companies. The company has two categories of services: Professional Employer Services, in which the company enters into a client services agreement to establish a co-employment relationship with each client company, assuming responsibility for payroll, payroll taxes, workers' compensation coverage and certain other administrative functions for the client's existing workforce; and Staffing, which includes on-demand or short-term staffing assignments, contract staffing, direct placement, and long-term or indefinite-term on-site management.

Northfield Bancorp is a savings and loan holding company. Through its subsidiary, Northfield Bank (the Bank), the company's business includes originating multifamily and other commercial real estate loans, purchasing investment securities, including mortgage-backed securities and corporate bonds, and, to a lesser extent, depositing funds in other financial institutions. The Bank also provides construction and land loans, commercial and industrial loans, and home equity loans and lines of credit, and purchases loan participations and pools of loans. The Bank provides a range of deposit accounts, including certificates of deposit, passbook, statement, and money market savings accounts, among others.

Plumas Bancorp is a bank holding company. Through its subsidiary, Plumas Bank, the company serves the financial needs of individuals and businesses. The company's retail lending services include consumer, automobile and home equity loans. The company's commercial lending services include term real estate, commercial and industrial term loans. The company also provides government- guaranteed and agricultural loans as well as credit lines. The company's deposit products for the retail and commercial banking markets including checking, interest-bearing and premium interest-bearing checking, business sweep, public funds sweep, savings, time deposit and retirement accounts, as well as remote deposit, telephone and mobile banking.

Savara is an orphan lung disease company. The company's drug development pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor in development for pulmonary alveolar proteinosis and in development for nontuberculous mycobacterial lung infection; and AeroVanc, an inhaled vancomycin for treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis.

Walker & Dunlop is a holding company and conducts the majority of its operations through Walker & Dunlop, LLC, its operating company. The company originates, sells, and services a range of multifamily and other commercial real estate financing products, provides multifamily property sales brokerage services, and engages in commercial real estate investment management activities. The company's commercial real estate finance products include first mortgage, second trust, supplemental, construction, small-balance, and bridge/interim loans. The company provides property sales services to owners and developers of multifamily properties and commercial real estate investment management services for various investors.